Annual CFO
-$307.51 M
-$33.14 M-12.08%
31 December 2023
Summary:
Ionis Pharmaceuticals annual cash flow from operations is currently -$307.51 million, with the most recent change of -$33.14 million (-12.08%) on 31 December 2023. During the last 3 years, it has fallen by -$343.40 million (-956.77%). IONS annual CFO is now -151.01% below its all-time high of $602.91 million, reached on 31 December 2018.IONS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$114.99 M
+$4.89 M+4.08%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly cash flow from operations is currently -$114.99 million, with the most recent change of +$4.89 million (+4.08%) on 30 September 2024. Over the past year, it has dropped by -$5.97 million (-5.47%). IONS quarterly CFO is now -122.99% below its all-time high of $500.24 million, reached on 30 June 2018.IONS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$351.94 M
-$5.97 M-1.72%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM cash flow from operations is currently -$351.94 million, with the most recent change of -$5.97 million (-1.72%) on 30 September 2024. Over the past year, it has increased by +$188.63 million (+34.89%). IONS TTM CFO is now -150.46% below its all-time high of $697.45 million, reached on 31 March 2019.IONS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.1% | -5.5% | +34.9% |
| 3 y3 years | -956.8% | -106.9% | -369.8% |
| 5 y5 years | -151.0% | -797.9% | -292.0% |
IONS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -956.8% | at low | -156.4% | +42.6% | -371.8% | +34.9% |
| 5 y | 5 years | -151.0% | at low | -141.4% | +42.6% | -201.8% | +34.9% |
| alltime | all time | -151.0% | at low | -123.0% | +42.6% | -150.5% | +34.9% |
Ionis Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$114.99 M(-4.1%) | -$351.94 M(+1.7%) |
| June 2024 | - | -$119.88 M(-20.0%) | -$345.98 M(+7.0%) |
| Mar 2024 | - | -$149.94 M(-556.2%) | -$323.46 M(+5.2%) |
| Dec 2023 | -$307.51 M(+12.1%) | $32.87 M(-130.1%) | -$307.51 M(-43.1%) |
| Sept 2023 | - | -$109.02 M(+12.0%) | -$540.57 M(+18.6%) |
| June 2023 | - | -$97.36 M(-27.3%) | -$455.98 M(+21.0%) |
| Mar 2023 | - | -$133.99 M(-33.1%) | -$376.71 M(+37.3%) |
| Dec 2022 | -$274.37 M(-990.8%) | -$200.19 M(+719.5%) | -$274.37 M(-311.8%) |
| Sept 2022 | - | -$24.43 M(+35.0%) | $129.51 M(+31.7%) |
| June 2022 | - | -$18.10 M(-42.8%) | $98.37 M(+82.8%) |
| Mar 2022 | - | -$31.65 M(-115.5%) | $53.81 M(+74.7%) |
| Dec 2021 | $30.80 M(-14.2%) | $203.69 M(-466.5%) | $30.80 M(-141.1%) |
| Sept 2021 | - | -$55.57 M(-11.3%) | -$74.91 M(+153.0%) |
| June 2021 | - | -$62.65 M(+14.6%) | -$29.61 M(+164.9%) |
| Mar 2021 | - | -$54.66 M(-155.8%) | -$11.18 M(-131.1%) |
| Dec 2020 | $35.89 M(-89.6%) | $97.98 M(-1053.5%) | $35.89 M(-83.4%) |
| Sept 2020 | - | -$10.28 M(-76.8%) | $215.75 M(+1.2%) |
| June 2020 | - | -$44.22 M(+482.4%) | $213.22 M(-7.4%) |
| Mar 2020 | - | -$7.59 M(-102.7%) | $230.33 M(-33.4%) |
| Dec 2019 | $345.63 M(-42.7%) | $277.84 M(-2269.6%) | $345.63 M(+88.6%) |
| Sept 2019 | - | -$12.81 M(-52.8%) | $183.30 M(+7.8%) |
| June 2019 | - | -$27.11 M(-125.2%) | $170.10 M(-75.6%) |
| Mar 2019 | - | $107.70 M(-6.8%) | $697.45 M(+15.7%) |
| Dec 2018 | $602.91 M(+246.2%) | $115.51 M(-544.2%) | $602.91 M(+18.7%) |
| Sept 2018 | - | -$26.00 M(-105.2%) | $507.80 M(-9.7%) |
| June 2018 | - | $500.24 M(+3699.7%) | $562.52 M(+770.1%) |
| Mar 2018 | - | $13.16 M(-35.5%) | $64.65 M(-62.9%) |
| Dec 2017 | $174.15 M(-255.3%) | $20.40 M(-29.0%) | $174.15 M(+37.2%) |
| Sept 2017 | - | $28.72 M(+1115.4%) | $126.91 M(+3.6%) |
| June 2017 | - | $2.36 M(-98.1%) | $122.47 M(+41.9%) |
| Mar 2017 | - | $122.67 M(-557.0%) | $86.33 M(-177.0%) |
| Dec 2016 | -$112.11 M(-630.7%) | -$26.84 M(-210.5%) | -$112.11 M(-8.7%) |
| Sept 2016 | - | $24.29 M(-171.9%) | -$122.74 M(+10.8%) |
| June 2016 | - | -$33.78 M(-55.4%) | -$110.81 M(+837.7%) |
| Mar 2016 | - | -$75.77 M(+102.2%) | -$11.82 M(-155.9%) |
| Dec 2015 | $21.13 M(+236.1%) | -$37.47 M(-203.5%) | $21.13 M(-83.7%) |
| Sept 2015 | - | $36.22 M(-44.5%) | $129.28 M(+36.1%) |
| June 2015 | - | $65.21 M(-252.3%) | $95.01 M(-2355.1%) |
| Mar 2015 | - | -$42.83 M(-160.6%) | -$4.21 M(-167.0%) |
| Dec 2014 | $6.29 M(-90.1%) | $70.68 M(+3536.0%) | $6.29 M(-108.0%) |
| Sept 2014 | - | $1.94 M(-105.7%) | -$78.89 M(+425.4%) |
| June 2014 | - | -$34.02 M(+5.2%) | -$15.01 M(-136.0%) |
| Mar 2014 | - | -$32.33 M(+123.1%) | $41.74 M(-34.3%) |
| Dec 2013 | $63.49 M(+3284.5%) | -$14.49 M(-122.0%) | $63.49 M(-44.3%) |
| Sept 2013 | - | $65.82 M(+189.5%) | $114.02 M(+388.8%) |
| June 2013 | - | $22.74 M(-315.0%) | $23.33 M(-1272.9%) |
| Mar 2013 | - | -$10.58 M(-129.3%) | -$1.99 M(-206.0%) |
| Dec 2012 | $1.88 M(-101.7%) | $36.03 M(-244.9%) | $1.88 M(-103.3%) |
| Sept 2012 | - | -$24.87 M(+865.1%) | -$56.90 M(+3.1%) |
| June 2012 | - | -$2.58 M(-61.6%) | -$55.20 M(-29.9%) |
| Mar 2012 | - | -$6.71 M(-70.5%) | -$78.80 M(-29.6%) |
| Dec 2011 | -$111.93 M(+76.0%) | -$22.74 M(-1.8%) | -$111.93 M(-2.4%) |
| Sept 2011 | - | -$23.17 M(-11.5%) | -$114.69 M(+1.5%) |
| June 2011 | - | -$26.18 M(-34.3%) | -$112.95 M(+38.2%) |
| Mar 2011 | - | -$39.84 M(+56.2%) | -$81.74 M(+28.5%) |
| Dec 2010 | -$63.59 M(-41.4%) | -$25.50 M(+19.0%) | -$63.59 M(-8.4%) |
| Sept 2010 | - | -$21.43 M(-526.0%) | -$69.45 M(-13.5%) |
| June 2010 | - | $5.03 M(-123.2%) | -$80.28 M(-16.1%) |
| Mar 2010 | - | -$21.69 M(-30.8%) | -$95.73 M(-11.7%) |
| Dec 2009 | -$108.44 M(-151.1%) | -$31.36 M(-2.8%) | -$108.44 M(+12.7%) |
| Sept 2009 | - | -$32.26 M(+209.4%) | -$96.25 M(+12.5%) |
| June 2009 | - | -$10.43 M(-69.7%) | -$85.55 M(-183.4%) |
| Mar 2009 | - | -$34.40 M(+79.4%) | $102.52 M(-51.6%) |
| Dec 2008 | $212.03 M(+487.4%) | -$19.18 M(-11.0%) | $212.03 M(-23.5%) |
| Sept 2008 | - | -$21.55 M(-112.1%) | $277.06 M(-10.9%) |
| June 2008 | - | $177.64 M(+136.5%) | $311.02 M(+135.6%) |
| Mar 2008 | - | $75.11 M(+63.8%) | $132.00 M(+265.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $36.09 M(-167.8%) | $45.86 M(+269.7%) | $36.09 M(-293.7%) |
| Sept 2007 | - | $12.40 M(-1004.7%) | -$18.63 M(-58.6%) |
| June 2007 | - | -$1.37 M(-93.4%) | -$44.99 M(-22.4%) |
| Mar 2007 | - | -$20.80 M(+134.4%) | -$57.96 M(+8.9%) |
| Dec 2006 | -$53.23 M(-12.8%) | -$8.87 M(-36.4%) | -$53.23 M(-8.3%) |
| Sept 2006 | - | -$13.96 M(-2.6%) | -$58.02 M(+15.9%) |
| June 2006 | - | -$14.33 M(-10.8%) | -$50.05 M(-9.1%) |
| Mar 2006 | - | -$16.06 M(+17.5%) | -$55.08 M(-9.8%) |
| Dec 2005 | -$61.04 M(-40.0%) | -$13.67 M(+128.6%) | -$61.04 M(-15.4%) |
| Sept 2005 | - | -$5.98 M(-69.1%) | -$72.15 M(-18.3%) |
| June 2005 | - | -$19.36 M(-12.1%) | -$88.26 M(-12.0%) |
| Mar 2005 | - | -$22.03 M(-11.1%) | -$100.32 M(-1.4%) |
| Dec 2004 | -$101.75 M(+6.6%) | -$24.78 M(+12.2%) | -$101.75 M(-7.0%) |
| Sept 2004 | - | -$22.09 M(-29.7%) | -$109.38 M(-0.6%) |
| June 2004 | - | -$31.42 M(+33.9%) | -$110.05 M(+9.0%) |
| Mar 2004 | - | -$23.47 M(-27.6%) | -$100.94 M(+5.7%) |
| Dec 2003 | -$95.47 M(+1.2%) | -$32.41 M(+42.4%) | -$95.47 M(+30.6%) |
| Sept 2003 | - | -$22.76 M(+2.0%) | -$73.08 M(+14.3%) |
| June 2003 | - | -$22.30 M(+23.9%) | -$63.91 M(-33.9%) |
| Mar 2003 | - | -$18.00 M(+79.7%) | -$96.66 M(+2.4%) |
| Dec 2002 | -$94.38 M(+1432.7%) | -$10.02 M(-26.3%) | -$94.38 M(-1.0%) |
| Sept 2002 | - | -$13.59 M(-75.3%) | -$95.30 M(+80.8%) |
| June 2002 | - | -$55.05 M(+249.9%) | -$52.71 M(+992.3%) |
| Mar 2002 | - | -$15.73 M(+43.9%) | -$4.83 M(-21.6%) |
| Dec 2001 | -$6.16 M(-73.4%) | -$10.93 M(-137.7%) | -$6.16 M(+438.3%) |
| Sept 2001 | - | $29.00 M(-505.0%) | -$1.14 M(-95.9%) |
| June 2001 | - | -$7.16 M(-58.0%) | -$28.02 M(-4.0%) |
| Mar 2001 | - | -$17.06 M(+188.3%) | -$29.20 M(+25.9%) |
| Dec 2000 | -$23.19 M(-52.1%) | -$5.92 M(-379.5%) | -$23.19 M(-18.0%) |
| Sept 2000 | - | $2.12 M(-125.4%) | -$28.27 M(-28.2%) |
| June 2000 | - | -$8.33 M(-24.6%) | -$39.38 M(-13.4%) |
| Mar 2000 | - | -$11.05 M(+0.5%) | -$45.45 M(-6.1%) |
| Dec 1999 | -$48.40 M(+39.5%) | -$11.00 M(+22.2%) | -$48.40 M(+1.9%) |
| Sept 1999 | - | -$9.00 M(-37.5%) | -$47.50 M(-1.0%) |
| June 1999 | - | -$14.40 M(+2.9%) | -$48.00 M(+52.4%) |
| Mar 1999 | - | -$14.00 M(+38.6%) | -$31.50 M(-9.2%) |
| Dec 1998 | -$34.70 M(+68.4%) | -$10.10 M(+6.3%) | -$34.70 M(+12.7%) |
| Sept 1998 | - | -$9.50 M(-552.4%) | -$30.80 M(+28.3%) |
| June 1998 | - | $2.10 M(-112.2%) | -$24.00 M(-29.6%) |
| Mar 1998 | - | -$17.20 M(+177.4%) | -$34.10 M(+65.5%) |
| Dec 1997 | -$20.60 M(-2.8%) | -$6.20 M(+129.6%) | -$20.60 M(+0.5%) |
| Sept 1997 | - | -$2.70 M(-66.3%) | -$20.50 M(-13.5%) |
| June 1997 | - | -$8.00 M(+116.2%) | -$23.70 M(+0.9%) |
| Mar 1997 | - | -$3.70 M(-39.3%) | -$23.50 M(+10.8%) |
| Dec 1996 | -$21.20 M(+40.4%) | -$6.10 M(+3.4%) | -$21.20 M(-3.6%) |
| Sept 1996 | - | -$5.90 M(-24.4%) | -$22.00 M(+43.8%) |
| June 1996 | - | -$7.80 M(+457.1%) | -$15.30 M(+39.1%) |
| Mar 1996 | - | -$1.40 M(-79.7%) | -$11.00 M(-27.2%) |
| Dec 1995 | -$15.10 M(-0.7%) | -$6.90 M(-962.5%) | -$15.10 M(+34.8%) |
| Sept 1995 | - | $800.00 K(-122.9%) | -$11.20 M(-20.0%) |
| June 1995 | - | -$3.50 M(-36.4%) | -$14.00 M(+0.7%) |
| Mar 1995 | - | -$5.50 M(+83.3%) | -$13.90 M(-8.6%) |
| Dec 1994 | -$15.20 M(-0.7%) | -$3.00 M(+50.0%) | -$15.20 M(+7.0%) |
| Sept 1994 | - | -$2.00 M(-41.2%) | -$14.20 M(-2.1%) |
| June 1994 | - | -$3.40 M(-50.0%) | -$14.50 M(-15.7%) |
| Mar 1994 | - | -$6.80 M(+240.0%) | -$17.20 M(+12.4%) |
| Dec 1993 | -$15.30 M(-21.1%) | -$2.00 M(-13.0%) | -$15.30 M(-13.6%) |
| Sept 1993 | - | -$2.30 M(-62.3%) | -$17.70 M(-7.3%) |
| June 1993 | - | -$6.10 M(+24.5%) | -$19.10 M(+9.8%) |
| Mar 1993 | - | -$4.90 M(+11.4%) | -$17.40 M(-10.3%) |
| Dec 1992 | -$19.40 M(+1193.3%) | -$4.40 M(+18.9%) | -$19.40 M(+23.6%) |
| Sept 1992 | - | -$3.70 M(-15.9%) | -$15.70 M(+4.7%) |
| June 1992 | - | -$4.40 M(-36.2%) | -$15.00 M(+38.9%) |
| Mar 1992 | - | -$6.90 M(+885.7%) | -$10.80 M(+620.0%) |
| Dec 1991 | -$1.50 M | -$700.00 K(-76.7%) | -$1.50 M(+87.5%) |
| Sept 1991 | - | -$3.00 M(+1400.0%) | -$800.00 K(-136.4%) |
| June 1991 | - | -$200.00 K(-108.3%) | $2.20 M(-8.3%) |
| Mar 1991 | - | $2.40 M | $2.40 M |
FAQ
- What is Ionis Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual CFO year-on-year change?
- What is Ionis Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly CFO year-on-year change?
- What is Ionis Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM CFO year-on-year change?
What is Ionis Pharmaceuticals annual cash flow from operations?
The current annual CFO of IONS is -$307.51 M
What is the all time high annual CFO for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual cash flow from operations is $602.91 M
What is Ionis Pharmaceuticals annual CFO year-on-year change?
Over the past year, IONS annual cash flow from operations has changed by -$33.14 M (-12.08%)
What is Ionis Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of IONS is -$114.99 M
What is the all time high quarterly CFO for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly cash flow from operations is $500.24 M
What is Ionis Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, IONS quarterly cash flow from operations has changed by -$5.97 M (-5.47%)
What is Ionis Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of IONS is -$351.94 M
What is the all time high TTM CFO for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM cash flow from operations is $697.45 M
What is Ionis Pharmaceuticals TTM CFO year-on-year change?
Over the past year, IONS TTM cash flow from operations has changed by +$188.63 M (+34.89%)